Table 2 Baseline data of COVID-19 patients from the LEOSS cohort

Patients, n(%)

6672 (100%)

5242 (78.6%)

1430 (21.4%)

Follow-up in hospital (days), median (IQR)

8 (4–15)

9 (5–16)

5 (2–11)

Age (years)

 0–14

68 (1.0%)

63 (1.2%)

5 (0.3%)

0.95 (0.39–2.33)

0.90 (0.37–2.22)

 15–25

173 (2.6%)

168 (3.2%)

5 (0.3%)

0.37 (0.15–0.93)

0.41 (0.17–1.03)

 26–35

362 (5.4%)

344 (6.6%)

18 (1.3%)

0.64 (0.38–1.10)

0.65 (0.38–1.12)

 36–45

531 (8.0%)

490 (9.3%)

41 (2.9%)

1

1

 46–55

915 (13.7%)

778 (14.8%)

137 (9.6%)

1.94 (1.39–2.70)

1.85 (1.33–2.58)

 56–65

1176 (17.6%)

955 (18.2%)

221 (15.5%)

2.43 (1.77–3.34)

2.34 (1.70–3.21)

 66–75

1158 (17.4%)

889 (17.0%)

269 (18.8%)

3.01 (2.20–4.11)

2.94 (2.16–4.02)

 76–85

1616 (24.2%)

1153 (22.0%)

463 (32.4%)

3.71 (2.74–5.03)

3.73 (2.76–5.05)

 > 85

673 (10.1%)

402 (7.7%)

271 (19.0%)

5.22 (3.83–7.10)

5.65 (4.16–7.69)

 Missing

–

–

–

Sex, n(%)

 Male

3777 (56.6%)

2817 (53.7%)

960 (67.1%)

1.57 (1.42–1.73)

1.69 (1.53–1.86)

 Female

2895 (43.4%)

2425 (46.3%)

470 (32.9%)

1

1

 Missing

–

–

–

BMI, n(%)

 < 18.5–24.9

1367 (20.5%)

1077 (20.5%)

290 (20.3%)

1

1

 25.0–29.9

1432 (21.5%)

1081 (20.6%)

351 (24.5%)

1.16 (1.01–1.32)

1.15 (1.00–1.31)

 30.0–34.9

772 (11.6%)

590 (11.3%)

182 (12.7%)

1.11 (0.94–1.31)

1.20 (1.02–1.41)

 ≥ 35.0

383 (5.7%)

290 (5.5%)

93 (6.5%)

1.14 (0.93–1.40)

1.42 (1.16–1.74)

 Missing

2718 (40.7%)

2204 (42.0%)

514 (35.9%)

–